Hisky is honored to have participated in the EASL Congress 2025, showcasing our iLivTouch® systems as a centerpiece of non-invasive liver innovation. We welcomed on our booth and engaged at the working sessions with global experts, KOLs, and partners, with widespread engagement around our breakthrough technologies, including advanced liver inflammation and spleen assessment functions.
Key Highlights:
🌟 #iLivTouch® Spotlight: The Plus9000 and Mini800 systems drew extensive interest, with visitors exploring their potential in drug development, general health monitoring, and precision diagnostics.
🌟 Strategic Collaborations: Hisky engaged with KOLs spanning Europe, Africa, and Asia, highlighting our technology’s versatility in addressing unmet needs. Feedback on portable, multi-functional devices for inflammation and organ analysis underscored strong alignment with current liver health needs.
🌟 Global Partnerships: We forged meaningful connections to advance liver health initiatives and screening innovations.
This event reaffirms Hisky’s role as a global pioneer in redefining liver diagnostics. Together, we’re driving the future of precision medicine!
